Crossref

1. Short-course versus long-course neoadjuvant chemoradiotherapy in patients with rectal cancer: preliminary results of a randomized controlled trial

- Mahdi Aghili

- Nastaran Khalili

- Neda Khalili

- Mohammad Babaei

- Farshid Farhan

- Peiman Haddad

- Samaneh Salarvand

- Amir Keshvari

- Mohammad Sadegh Fazeli

- Negin Mohammadi

- Reza Ghalehtaki

2. A single-institution retrospective analysis of outcomes for locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy

- Kannan Venkatesan

- Vivek Anand

- Ranjeet Bajpai

- RohitSantosh Kabre

- Asha Kapadia

- Sachin Almel

- Muzammil Shaikh

- Vinay Babu

- Ajay Kolse

- Ganesh Nagrajan

- Murad Lala

- Smruti krishna

- P Jagannath

- Sudesh Deshpande

3. A randomized phase 3 trial of total neoadjuvant therapy (induction chemotherapy, neoadjuvant chemoradiation, neoadjuvant chemotherapy, and surgery) vs. standard long-term chemoradiation therapy (neoadjuvant chemoradiation, surgery, and adjuvant chemotherapy) in locally advanced rectal cancer

- Freshte Foroughi

- Seyed Alireza Javadinia

- Roham Salek